A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...

When dementia is diagnosed early on, there are more treatment and management options.Dr. Sudha Seshadri — the founding director of the Alzheimer’s and neurodegenerative diseases institute at UT Health ...

The study revealed that having both slow walking speed and weak grip strength increased the risk of developing dementia by 79 ...

A groundbreaking study reveals how a rare combination of genetics, proteomics, and environmental factors may hold the key to delaying or preventing Alzheimer's, challenging long-held assumptions about ...

The largest trial to date comparing different dementia care management programs found that family caregiver self-efficacy — a measurement of caregivers’ confidence in managing dementia-related ...

Biotech giant Biogen Inc (NASDAQ:BIIB) is scheduled to report fourth-quarter earnings on 12 February. The Wall Street ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

In a significant legislative move, Florida Senator Danny Burgess’ (R-Zephyrhills) recent filing of Senate Bill 398 could mark ...

Smoking and obesity synergistically worsened disease progression and cognitive performance in multiple sclerosis (MS) in a ...

Some two years into Leqembi’s launch, Eisai continues to go all-in on its Alzheimer’s disease-fighting antibody, which the ...

Researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ultimately did not have the disease in a study aimed at identifying factors that contribute to misdiagnosis ...

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...